James DeYonker is an experienced Legal executive with a 20+ year track record in the life sciences industry encompassing corporate, commercial, intellectual property and legal compliance. Previously, he served as the Chief Legal, Compliance and IP Officer of EuroAPI, a Paris-based CDMO, which was spun out of Sanofi Pharmaceuticals in 2022 and listed on the Paris Stock Exchange. Prior this role, James was the Chief Legal, Compliance, and IP Officer of Centrient Pharmaceuticals, a Bain Capital Private Equity portfolio company, based in the Netherlands and focused on the enzymatic production of antibiotics.  Earlier in his career, James was in private practice at Linklaters LLP and worked with a variety of active pharmaceutical manufacturers.  James holds a Bachelor of Science degree in molecular biology from Emory University and a Juris Doctorate in Law from Rutgers University.  James is also a registered US patent attorney.